Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene

Journal of Steroid Biochemistry and Molecular Biology

Volumn 116, Issue 1-2, 2009, Pages 93-101

  Daverey, Amita ^a   Saxena, Ruchi ^a   Tewari, Shikha ^b   Goel, Sudhir K ^b   Dwivedi, Anila ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b Indian Institute of Toxicological Research   (India)

Author keywords

Co regulators; Estrogen receptor; Ormeloxifene; Tamoxifen; Uterus

Indexed keywords

CENTCHROMAN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NUCLEAR RECEPTOR COREPRESSOR; PROGESTERONE RECEPTOR; RECEPTOR INTERACTING PROTEIN 140; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; FEMALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BLOCKING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BENZOPYRANS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HISTONE ACETYLTRANSFERASES; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; UTERUS;

RATTUS;

EID: 67449089596     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.05.006     Document Type: Article

References (54)

1. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
2. Kininis M., and Kraus W.L. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl. Receptor Signal. 6 (2008) e005
3. Kuiper G., Enmark E., Pelto-Huikko M., Nilsson M.S., and Gustafsson J.A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5925-5930
4. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., and Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87 (2007) 905-931
5. Dahlman-Wright K., Cavailles V., Fuqua S.A., Jordan V.C., Katzenellenbogen J.A., Korach K.S., Maggi A., Muramatsu M., Parker M.G., and Gustafsson J.A. International union of pharmacology, LXIV, estrogen receptors. Pharmacol. Rev. 58 (2006) 773-781
6. Chang E.C., Charn T.H., Park S.H., Helferich W.G., Komm B., Katzenellenbogen J.A., and Katzenellenbogen B.S. Estrogen receptors α and β as determinants of gene expression: Influence of ligand, dose, and chromatin binding. Mol. Endocrinol. 22 (2008) 1032-1043
7. Tsai R.S., Carrupt P.A., Testa B., and Caldwell J. Structure-genotoxicity relationships of allylbenzenes and propenylbenzenes: a quantum chemical study. Chem. Res. Toxicol. 7 (1994) 73-76
8. Leo C., and Chen J.D. The SRC family of nuclear receptor coactivators. Gene 245 (2000) 1-11
9. Kininis M., Chen B.S., Diehl A.G., Isaacs G.D., Zhang T., Siepel A.C., Clark A.G., and Kraus W.L. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell. Biol. 27 (2007) 5090-5104
10. Lonard D.M., and Smith C.L. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions. Steroids 67 (2002) 15-24
11. Li H., Leo C., Schroen D.J., and Chen J.D. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11 (1997) 2025-2037
12. Smith C.L., Nawaz Z., and O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11 (1997) 657-666
13. Chien P.Y., Ito M., Park Y., Tagami T., Gehm B.D., and Jameson J.L. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. Mol. Endocrinol. 13 (1999) 2122-2136
14. List H.J., Lauritsen K.J., Reiter R., Powers C., Wellstein A., and Riegel A.T. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J. Biol. Chem. 276 (2001) 23763-23768
15. Singh M.M. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med. Res. Rev. 21 (2001) 302-347
16. Durani S., and Anand N. A possible basis for structure function relationship of estrogens. Int. J. Quantum Chem. XX (1981) 71-76
17. Dwivedi A., Basu R., Chowdhury S.R., and Goyal N. Modulation of estrogen action during pre-implantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene. Contraception 71 (2005) 458-464
18. Blesson C.S., Awasthi S., Kharkwal G., Daverey A., and Dwivedi A. Modulation of estrogen receptor transactivation and estrogen induced genes expression by Ormeloxifene-a triphenylethylene derivative. Steroids 71 (2006) 993-1000
19. Bain S.D., Graenn S., Kurmanat S.M., Guldhammar B., and Korsgaard N. Levormeloxifene, a nonsteroidal, partial estrogen agonist, prevent bone loss, reduces serum cholesterol and exerts a nonproliferative action on uterine tissue in ovariectomized rat. J. Bone Miner. Res. 12 Suppl. 1 (1997) (Abstract S347)
20. Arshad M., Sengupta S., Sharma S., Ghosh R., Sawlani V., and Singh M.M. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by Ormeloxifene, a selective estrogen receptor modulator. J. Steroid Biochem. Mol. Biol. 19 (2004) 67-78
21. Narayana-Murthy P.S., Sengupta S., Sharma S., and Singh M.M. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF-beta-3 expression. J. Steroid Biochem. Mol. Biol. 100 (2006) 117-128
22. Srivastava S., Sharma R., and Balapure A.K. Morphological and biochemical basis of centchroman as a novel antineoplastic agent in MCF-7 human breast cancer cells. Indian J. Pharmacol. 36 (2004) 238-243
23. Navarro D., Leon L., Chirino R., Fernandez L., Pestano J., and Diaz-Chico B. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissue display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element. J. Steroid Biochem. Mol. Biol. 64 (1998) 49-58
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) 2002-2007
25. Cheskis B.J., Karathanasis S., and Lyttle C.R. Estrogen receptor ligands modulate its interaction with DNA. J. Biol. Chem. 272 (1997) 11384-11391
26. Klinge C.M., Jernigan S.C., Smith S.L., Tyulmenkov V.V., and Kulakosky P.C. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol. Cell. Endocrinol. 174 (2001) 151-166
27. Nephew K.P., Long X., Osborne E., Burke K.A., Ahluwalia A., and Bigsby R.M. Effect of estradiol on estrogen receptor expression in the rat uterine cell types. Biol. Reprod. 62 (2000) 168-177
28. Varayoud J., Ramos J.G., Monje L., Bosquiazzo V., Muñoz-de-Toro M., and Luque E.H. The estrogen receptor α Σ3 mRNA splicing variant is differentially regulated by estrogen and progesterone in the rat uterus. J. Endocrinol. 186 (2005) 51-60
29. Fan M., Nakshatri H., and Nephew P.K. Inhibiting proteasomal poteolysis sustains estrogen receptor-α activation. Mol. Endocrinol. 18 (2004) 2603-2615
30. Calligé M., and Richard-Foy H. Ligand-induced estrogen receptor α degradation by the proteasome: new actors?. Nucl. Receptor Signal. 4 (2006) e004
31. Kurita T., Lee K.J., Cooke P.S., Taylor J.A., Lubahn D.B., and Cunha G.R. Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract. Biol. Reprod. 62 (2001) 821-830
32. Kraus W.L., and Katzenellenbogen B.S. Regulation of progesterone receptor gene expression in rat uterus: modulation of estrogen action by progesterone and sex steroid hormone antagonists. Endocrinology 132 (1993) 2371-2379
33. Parczyk K., Madjno R., Michna H., Nishino Y., and Schneider M.R. Progesterone receptor repression by estrogens in rat uterine epithelial cells. J. Steroid Biochem. Mol. Biol. 63 (1997) 309-316
34. O'Malley B.W. Molecular biology: little molecules with big goals. Science 313 (2006) 1749-1750
35. Shang Y., and Brown M. Molecular determinants for the tissue specificity of SERMs. Science 295 (2002) 2465-2468
36. Freedman L.P. Increasing the complexity of coactivation in nuclear receptor. Cell 97 (1999) 5-8
37. Zhang X., Jeyakumar M., Petukhov S., and Bagchi M.K. A nuclear receptor co-repressor modulates transcriptional activity of antagonist occupied steroid hormone receptor. Mol. Endocrinol. 12 (1998) 513-524
38. Huang H.J., Norris J.D., and McDonnell D.P. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular response to agonist and antagonist. Mol. Endocrinol. 16 (2002) 1778-1792
39. Gregory C.W., Wilson E.M., Apparao K.B., Lininger R.A., Meyer W.R., and Kowalik A. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J. Clin. Endocrinol. Metab. 87 (2002) 2960-2966
40. Shiozawa T., Shih H.C., Miyamoto T., Feng Y.Z., Uchikawa J., and Itoh K. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J. Clin. Endocrinol. Metab. 88 (2003) 871-878
41. Nephew K.P., Ray S., Hlaing M., Ahluwalia A., Wu S.D., Long X., Hyder S.M., and Bigsby R.M. Expression of estrogen receptor coactivators in the rat uterus. Biol. Reprod. 63 (2000) 361-367
42. Quezada S., Avellaira C., Johnson M.C., Gabler F., Fuentes A., and Vega M. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil. Steril. 85 (2006) 1017-1026
43. Uchikawa J., Shiozawa T., Shih H.C., Miyamoto T., Feng Y.Z., Kashima H., Oka K., and Konishi I. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and ki-67 expression. Cancer 98 (2003) 2207-2213
44. Thenot S., Charpin M., Bonnet S., and Cavailles V. Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol. Cell. Endocrinol. 156 (1999) 85-93
45. Wong C.W., Komm B., and Cheskis B.J. Structure-function evaluation of ERα and β interplay with SRC family coactivators-ER selective ligands. Biochemistry 40 (2001) 6756-6765
46. Cheskis B.J., McKenna N.J., Wong C.W., Wong J., Komm B., Lyttle C.R., and O'Malley B.W. Hierarchical affinities and a bipartite interaction model for estrogen receptor isoforms and full-length steroid receptor coactivator (SRC/p160) family members. J. Biol. Chem. 278 (2003) 13271-13277
47. White J.H., Fernandes I., Mader S., and Yang X.J. Corepressor recruitment by agonist-bound nuclear receptors. Vitam. Horm. 68 (2004) 123-143
48. Augereau P., Badia E., Carascossa S., Castet A., Fritsch S., Harmand P.O., Jalaguier S., and Cavaillès V. The nuclear receptor transcriptional coregulator RIP140. Nucl. Receptor Signal. 4 (2006) e024
49. Treuter E., Albrektsen T., Johansson L., Leers J., and Gustafsson J.A. A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12 (1998) 864-881
50. Hu X., and Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 387 (1999) 733-736
51. Wu Y., Kawate H., Ohnaka K., Nawata H., and Takayanagi R. Nuclear compartmentalization of N-CoR and its interactions with steroid receptors. Mol. Cell. Biol. 26 (2006) 6633-6655
52. Lavinsky R., Jepsen K., and Heinzel T. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 2920-2925
53. Webb P., Nguyen P., and Kushner P.J. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. J. Biol. Chem. 278 (2003) 6912-6920
54. Flemming F.J., Myers E., Kelly G., Crotty T.B., McDermott E.W., O'Higgins N.J., Hill A.D.K., and Young L.S. Expression of SRC-1,AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J. Clin. Pathol. 57 (2004) 1069-1074